N@N

Cerus to Release Fourth Quarter and Year End 2008 Financial Results on February 26, 2009

_{//health-fitness.news-articles.net/content/2009/ .. -2008-financial-results-on-february-26-2009.html}
^{Published in Health and Fitness on Thursday, February 12th 2009 at 13:07 GMT, Last Modified on 2009-02-12 13:08:02 by Market Wire}  

CONCORD, Calif.--([ BUSINESS WIRE ])--Cerus Corporation (NASDAQ:CERS) announced today that its fourth quarter and year end 2008 financial results will be released on Thursday, February 26, 2009, and that it will host a conference call and live webcast at 4:30 p.m. EDT that afternoon. Management will discuss the company's financial results and provide an overview of the company at that time.

To access the webcast, log on to the Investor Relations page of the Cerus Web site at [ www.cerus.com ]. Alternatively, you may access the live conference call by dialing 877-407-0782 (U.S.) or 201-689-8567 (International). A telephone and webcast replay will be available approximately two hours after the call through March 5, 2009. The replay can be accessed by dialing 877-660-6853 (U.S.) or 201-612-7415 (International), and entering account number 286 and conference ID number 285647. The webcast will be archived on [ www.cerus.com ].

ABOUT CERUS

Cerus Corporation is a biomedical products company focused on commercializing the INTERCEPT Blood System to enhance blood safety. The INTERCEPT Blood System is designed to inactivate blood-borne pathogens in donated blood components intended for transfusion. Cerus currently markets the INTERCEPT Blood System for both platelets and plasma in Europe, Russia, the Middle East and selected countries in other regions around the world. The Company is also pursuing regulatory approvals in the United States and other countries. The INTERCEPT red blood cell system is currently in clinical development.

INTERCEPT and the INTERCEPT Blood System are trademarks of Cerus Corporation.